Coloplast A/S OTC:CLPBY

Coloplast A/S stock price today

$9.46
-1.58
-14.39%
Financial Health
0
1
2
3
4
5
6
7
8
9

Coloplast A/S stock price monthly change

-13.94%
month

Coloplast A/S stock price quarterly change

-13.94%
quarter

Coloplast A/S stock price yearly change

-4.49%
year

Coloplast A/S key metrics

Market Cap
26.28B
Enterprise value
185.22B
P/E
3.50
EV/Sales
6.85
EV/EBITDA
21.61
Price/Sales
6.04
Price/Book
0.98
PEG ratio
N/A
EPS
17.62
Revenue
24.98B
EBITDA
8.11B
Income
4.90B
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
18.69%
Oper. margin
27.25%
Gross margin
67.59%
EBIT margin
27.25%
EBITDA margin
32.49%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Coloplast A/S stock price history

Coloplast A/S stock forecast

Coloplast A/S financial statements

Coloplast A/S (OTC:CLPBY): Profit margin
Mar 2023 6.06B 1.15B 19.06%
Jun 2023 6.10B 1.27B 20.83%
Sep 2023 6.22B 1.22B 19.74%
Mar 2024 6.58B 1.25B 19.01%
Coloplast A/S (OTC:CLPBY): Analyst Estimates
2025 28.94B 585.66M 2.02%
2026 31.40B 651.23M 2.07%
2027 33.99B 738.86M 2.17%
2028 36.81B 858.36M 2.33%
  • Analysts Price target

  • Financials & Ratios estimates

11.06%
Yield TTM
Coloplast A/S (OTC:CLPBY): Payout ratio
Payout ratio 93.43%
Coloplast A/S (OTC:CLPBY): Dividend Yield
2020 16.97%
2021 17.9%
2022 24.58%
2023 26.45%
2024
Coloplast A/S (OTC:CLPBY): Debt to assets
Mar 2023 35302000000 28.26B 80.07%
Jun 2023 35087000000 28.59B 81.5%
Sep 2023 48159000000 30.86B 64.08%
Mar 2024 48140000000 31.94B 66.35%
Coloplast A/S (OTC:CLPBY): Cash Flow
Mar 2023 689M -106M -623M
Jun 2023 1.16B -274M -655M
Sep 2023 1.88B -8.30B 6.46B
Mar 2024 -2.56B -287M 2.80B

Coloplast A/S alternative data

Coloplast A/S (OTC:CLPBY): Employee count
Aug 2023 14,973
Sep 2023 14,700
Oct 2023 14,700
Nov 2023 14,700
Dec 2023 15,692
Jan 2024 15,692
Feb 2024 15,692
Mar 2024 15,751
Apr 2024 15,751
May 2024 15,751
Jun 2024 15,930
Jul 2024 15,930

Coloplast A/S other data

Wednesday, 11 December 2024
globenewswire.com
Thursday, 5 December 2024
globenewswire.com
Saturday, 9 November 2024
seekingalpha.com
Monday, 21 October 2024
globenewswire.com
Wednesday, 25 September 2024
globenewswire.com
globenewswire.com
Tuesday, 3 September 2024
globenewswire.com
globenewswire.com
Friday, 30 August 2024
globenewswire.com
globenewswire.com
Thursday, 22 August 2024
zacks.com
Tuesday, 20 August 2024
seekingalpha.com
Friday, 10 May 2024
seekingalpha.com
Friday, 8 March 2024
globenewswire.com
Wednesday, 6 March 2024
globenewswire.com
Friday, 1 March 2024
globenewswire.com
Wednesday, 28 February 2024
globenewswire.com
Friday, 9 February 2024
globenewswire.com
globenewswire.com
Sunday, 12 November 2023
Seeking Alpha
Thursday, 17 August 2023
Seeking Alpha
Friday, 7 July 2023
Reuters
Friday, 3 February 2023
Seeking Alpha
Wednesday, 17 August 2022
Seeking Alpha
Friday, 3 June 2022
Seeking Alpha
  • What's the price of Coloplast A/S stock today?

    One share of Coloplast A/S stock can currently be purchased for approximately $9.46.

  • When is Coloplast A/S's next earnings date?

    Coloplast A/S is estimated to report earnings on Friday, 5 Dec 2025.

  • Does Coloplast A/S pay dividends?

    Yes, Coloplast A/S pays dividends and its trailing 12-month yield is 11.06% with 93% payout ratio. The last Coloplast A/S stock dividend of undefined was paid on 5 Sep 2025.

  • How much money does Coloplast A/S make?

    Coloplast A/S has a market capitalization of 26.28B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 10.33% to 27.03B US dollars.

  • What is Coloplast A/S's stock symbol?

    Coloplast A/S is traded on the OTC under the ticker symbol "CLPBY".

  • What is Coloplast A/S's primary industry?

    Company operates in the Healthcare sector and Medical Instruments & Supplies industry.

  • How do i buy shares of Coloplast A/S?

    Shares of Coloplast A/S can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Coloplast A/S have?

    As Jul 2024, Coloplast A/S employs 15,930 workers, which is 1% more then previous quarter.

  • When Coloplast A/S went public?

    Coloplast A/S is publicly traded company for more then 11 years since IPO on 13 Jan 2014.

  • What is Coloplast A/S's official website?

    The official website for Coloplast A/S is coloplast.com.

  • How can i contact Coloplast A/S?

    Coloplast A/S can be reached via phone at +45 49 11 11 11.

Coloplast A/S company profile:

Coloplast A/S

coloplast.com
Exchange:

OTC

Full time employees:

14,500

Industry:

Medical Instruments & Supplies

Sector:

Healthcare

Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, it offers voice and respiratory products, including medical devices for neck stoma under the Provox brand; and products for tracheostoma under the TRACOE brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Holtedam 1-3
Humlebæk, 3050

CIK: 0001294325
ISIN: US19624Y2000
: